Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Surveys and Questionnaires × Clear all

Phase

Phase NA 8 Phase 4 1 Phase 3 1

Status

Completed 4 Terminated 2 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Carboplatin 6 anlotinib 5 lenvatinib 4 Oxaliplatin 4 Cisplatin 4 tislelizumab 3 sintilimab 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Capecitabine 3 venetoclax 2 relatlimab 2 Rosuvastatin Calcium 2 Prednisone 2 Nivolumab 2 Leucovorin 2 Injections 2 Drug Therapy 2 Dexmedetomidine 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 Aspirin 2 zanubrutinib 1 xiaojin wan 1 trastuzumab deruxtecan 1 trametinib 1 testosterone 17 beta-cypionate 1 tenofovir alafenamide 1 telitacicept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07490509 2026-04-01

DOSABEMA

Poitiers University Hospital

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡